ICMR Transfers 3 Indigenous Biomedical Technologies
ICMR has transferred 3 indigenous biomedical technologies, including an anti-HPV candidate and enteric vaccines, to accelerate cancer and infectious disease solutions.
Biological E | 23/07/2026 | By News Bureau
Serum Institute and Bavarian Nordic Expand Partnership for Chikungunya Vaccine Manufacturing
Bavarian Nordic and Serum Institute of India have expanded their strategic partnership through a chikungunya vaccine manufacturing agreement, enabling full technology transfer and supporting future supply to low- and middle-income countries while opening opportunities for further co-development.
Biological E | 11/03/2026 | By News Bureau | 216
ICMR Licenses Nine Health Tech Innovations at India MedTech Expo 2025
At the India MedTech Expo 2025 in Delhi, ICMR licensed nine breakthrough technologies to industry partners under its Patent Mitra initiative, sealing 17 deals in diagnostics and vaccine development to advance affordable, homegrown healthcare.
Biological E | 05/09/2025 | By Dineshwori | 342
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy